Wyatt R. Hack

High Drinking in the Dark (HDID) mice are sensitive to the effects of some clinically relevant drugs to reduce binge-like drinking

J. Crabbe, A. Ozburn, A. Barkley-Levenson, 2017, Pharmacology Biochemistry and Behavior.

The novel estrogen receptor modulator STX attenuates Amyloid-β neurotoxicity in the 5XFAD mouse model of Alzheimer’s disease

J. Quinn, P. F. Copenhaver, M. Kelly, 2022, Neurobiology of Disease.

An alcohol withdrawal test battery measuring multiple behavioral symptoms in mice.

J. Crabbe, P. Metten, Lawrence C. Huang, 2017, Alcohol.

Targeting the glucocorticoid receptor reduces binge-like drinking in High Drinking in the Dark (HDID-1) mice.

J. Crabbe, H. Hunt, A. Savarese, 2020, Alcoholism, clinical and experimental research.

Fear conditioning in mouse lines genetically selected for binge-like ethanol drinking.

J. Crabbe, K. Lattal, A. Barkley-Levenson, 2016, Alcohol.

Ethanol Conditioned Taste Aversion in High Drinking in the Dark Mice

J. Crabbe, A. Savarese, A. Ozburn, 2019, Brain sciences.

Long‐term alcohol drinking in High Drinking in the Dark mice is stable for many months and does not show alcohol deprivation effects

J. Crabbe, A. Savarese, A. Ozburn, 2021, Addiction biology.

Tetracycline derivatives reduce binge alcohol consumption in High Drinking in the Dark mice

J. Crabbe, R. Hitzemann, A. Ozburn, 2020, Brain, behavior, & immunity - health.